Poonawalla Fincorp sells controlling stake in housing finance arm to Singapore company for Rs 3,004 crore

July 26, 2023

The Cyrus Poonawalla Group, more known for its vaccine-making business under the Serum Institute, in a statement said the financial consideration of Rs 3,004 crore is excluding the tax outgoes. With this sale, Poonawalla Housing Finance will cease to be a subsidiary of Poonawalla Fincorp, and Perseus will be holding a controlling stake.

More To Explore

FOMC meet, FII action among 8 factors that could drive D-Street this week

Nifty ended the week down 0.7% due to IT sector selling. Key factors to watch include the upcoming FOMC meeting, US market movements, potential impact

March 16, 2025

Smallcap stocks under stress but is it time to buy the fear?

Small-cap equities, after strong 2023-24 gains, slipped into a bear market but now show recovery potential. Supportive macro fundamentals, easing fiscal and monetary policies, sectoral

March 16, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003